# Antibiotics Continuous Infusion at Home

> **NCT04816968** · PHASE1 · UNKNOWN · sponsor: **Ospedale San Carlo Borromeo** · enrollment: 50 (estimated)

## Conditions studied

- Severe Bacterial Infections

## Interventions

- **DRUG:** Cefepime
- **DRUG:** Piperacillin/tazobactam
- **DRUG:** Meropenem
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT04816968
- **Lead sponsor:** Ospedale San Carlo Borromeo
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2023-09
- **Final completion:** 2023-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816968, "Antibiotics Continuous Infusion at Home". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04816968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*